Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc.

NAUTยทNASDAQ

$2.58

-3.7%
HealthcareBiotechnology

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

At a Glance

Live Snapshot
Market Cap$327.86M
EPS-0.4700
P/E Ratio-5.49
Earnings Date08/04/2026
3Y+11.0%
5Y+262.0%
10Y-79.0%
3Y-237.0%
5Y-239.0%
10Y+2839.0%
3Y-62.0%
5Y-100.0%
10Y-100.0%
NAUT

Nautilus Biotechnology, Inc. Cash Conversion Engine

NAUT ยท NASDAQ
Net Income-59.00M
Depreciation & Amortization6.46M
Stock-Based Compensation6.84M
Change in Working Capital-3.58M
Others-1.42M
Capital Expenditures-1.28M
Free Cash Flow-51.97M

Cash Flow Quality Analysis

FCF Conversion Rate

88.1%

Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.

CapEx Intensity

-2.5%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+15.2%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$3.58M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

Nautilus Biotechnology, Inc. Cash Flow Statement

NAUT โ€ข NASDAQ

Nautilus Biotechnology, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
OPERATING ACTIVITIES
-59M
-70.8M
-63.7M
-57.9M
-50.3M
-15.6M
-9.6M
626.6M
6.5M
6.4M
5.7M
3.4M
2.8M
2.3M
548K
0.0
6.8M
12.7M
12.1M
10.4M
7.9M
369K
110K
0.0
-1.4M
-2M
-2.7M
-890K
320K
295K
-157K
-866.2M
-3.6M
-5.5M
-3.2M
-788K
-22K
-1.4M
-545K
1.3M
-50.7M
-59.1M
-51.7M
-45.8M
-39.2M
-14M
-9.7M
-238.3M
INVESTING ACTIVITIES
-1.3M
-2.1M
-2.4M
-2.3M
-2.3M
-921K
-926K
(0.0)
-72.5M
-86.3M
-112.9M
-186.6M
-221.8M
-68.4M
(0.0)
(0.0)
109M
0.0
71.6M
163.2M
85.1M
44M
0.0
0.0
0.0
154.7M
0.0
0.0
0.0
0.0
5M
1.2M
(35.2M)
(66.3M)
-43.7M
-25.7M
-139M
-25.3M
(4.1M)
(1.2M)
FINANCING ACTIVITIES
214K
1.1M
368K
562K
-8M
0.0
0.0
0.0
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-874.3K
-1.2M
0.0
0.0
0.0
0.0
335.4M
42K
36K
145.2B
214K
1.1M
368K
562K
327.4M
75.9M
36K
145.2B
CASH FLOW SUMMARY
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-144.9B
-15.3M
8.2M
-95.1M
-71M
149.2M
36.6M
595K
1.2M
28.6M
20.4M
115.5M
186.5M
37.2M
595K
1.2M
0.0
13.4M
28.6M
20.4M
115.5M
186.5M
37.2M
595K
1.2M
-52M
-61.3M
-54.2M
-48.1M
-41.5M
-14.9M
-10.6M
-238.3M

SEC Filings

NAUT - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

April 28, 2026
April 28, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 28, 2026
June 17, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 28, 2026
March 31, 2026
2026
10-K

10-K 2025 FY

FY

February 26, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 26, 2026
February 26, 2026
2026
8-K

8-K 2025

N/A

November 04, 2025
November 03, 2025
2025
10-Q

10-Q 2025 Q3

Q3

October 28, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

October 28, 2025
October 28, 2025
2025
10-Q

10-Q 2025 Q2

Q2

July 31, 2025
June 30, 2025
2025
8-K

8-K 2025

N/A

July 31, 2025
July 31, 2025
2025
Showing 1 to 10 of 76 filings